Carer Involvement in Exercises for People With Acquired Brain Injury.

April 28, 2025 updated by: Norfolk and Norwich University Hospitals NHS Foundation Trust

Carer Involvement in Exercise Programmes for Acute Neurosciences Patients With Acquired Brain Injury

Increasing the amount of exercises completed has been shown to help recovery for people after a brain injury. This study will explore if providing extra training of exercises prescribed to a patient and carer team, will allow more practice of these exercises, better abilities to move and balance, and to assess if carer confidence changes with doing this. It is a repeated case design in the in-patient acute Neurosciences setting at the Norfolk and Norwich University Hospital NHS Trust (NNUH).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
      • Norwich, United Kingdom
        • Norfolk and Norwich University Hospitals NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion

  • Adults with acquired brain injury on NNUH Neurosciences Unit with a carer physically able to complete exercises with the patient.
  • Patient to be able to follow simple commands (1 stage) for exercise intervention.
  • Patient able to consent along with their relative together to participation in the study.

Exclusion:

  • Discharge plan for ESD from initial assessment with no care package required due to too short timeframe of being an acute in-patient.
  • Patient's with severe cognitive - communication deficits meaning they cannot follow 1 stage command for exercises or consent to the study.
  • Severe pain, joint abnormality or spasticity limiting participation in exercise programme.
  • Carer/relative not able to physically help the patient with the required exercises or carer/relative not able to consent to the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercises for people with acquired brain injury
Behavioral: five exercises prescribed and taught to carers and participants
Up to five exercises prescribed and taught to carers and participants in an acute hospital setting fort hem to continue to practice as able.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Log of exercise repetitions
Time Frame: Pre and post intervention: 4 weeks or at point of discharge from acute Trust.
Log of exercise repetitions completed by patient and relative/carer team (on exercise record log), VAS score (Visual analogue score) rating 0- no confidence to 10- very confident for carer confidence pre and post intervention.
Pre and post intervention: 4 weeks or at point of discharge from acute Trust.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Norfolk and Norwich University Hospitals NHS Foundation Trust

Collaborators

University of East Anglia
3 Million Steps charity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2024

Primary Completion (Actual)

August 23, 2024

Study Completion (Actual)

September 13, 2024

Study Registration Dates

First Submitted

April 2, 2025

First Submitted That Met QC Criteria

April 28, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 28, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 334551 (196-10-23)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe